SCHEMBL24028695

SCHEMBL24028695

N#Cc1ccccc1-c1cc(-n2c3ccccc3c3ccccc32)nc(-c2cccc(C(c3ccccc3)(c3ccccc3)c3ccccc3)c2)n1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ACP1 P24666 1/20 0.36
▸ GABRG2 P18507 5/20 0.35
▸ GABRB3 P28472 5/20 0.35
▸ GABRA5 P31644 4/20 0.35
▸ GABRA3 P34903 4/20 0.35
▸ PSD A5PKW4 1/20 0.33
▸ GABRA1 P14867 4/20 0.32
▸ ATR Q13535 1/20 0.32
▸ CYP1A2 P05177 6/20 0.32
▸ KMT2A Q03164 4/20 0.32
▸ CYP3A4 P08684 4/20 0.32
▸ MEN1 O00255 3/20 0.32
▸ ALDH1A1 P00352 3/20 0.32
▸ CYP2C19 P33261 3/20 0.32
▸ LMNA P02545 3/20 0.32
▸ CYP2D6 P10635 3/20 0.32
▸ TSHR P16473 3/20 0.32
▸ CLK4 Q9HAZ1 2/20 0.32
▸ MAPK1 P28482 2/20 0.32
▸ HSD17B10 Q99714 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24028268 0.92 PSD (0.36) ACP1GABRG2GABRB3GABRA5GABRA3
SCHEMBL24028686 0.85 GABRG2 (0.36) GABRG2GABRB3GABRA5GABRA3GABRA1
SCHEMBL24028693 0.85 TSHR (0.33) ALDH1A1LMNATSHRMAPK1HSD17B10
SCHEMBL25138184 0.85 MAPT (0.39) KMT2AMEN1ALDH1A1LMNATSHR
SCHEMBL24028265 0.85 MAPT (0.42) KMT2AMEN1ALDH1A1LMNATSHR
SCHEMBL24029082 0.84 ABCG2 (0.42) ACP1GABRG2GABRB3GABRA5GABRA3
SCHEMBL24029180 0.84 CYP1A2 (0.43) CYP1A2KMT2ACYP3A4MEN1ALDH1A1
SCHEMBL24028641 0.84 CYP1A2 (0.34) ACP1CYP1A2KMT2ACYP3A4MEN1
SCHEMBL22549402 0.83 HTT (0.38) CYP1A2KMT2ACYP3A4MEN1ALDH1A1
SCHEMBL24029053 0.82 MAPT (0.33) LMNATSHRMAPK1HSD17B10MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210359215-A1 COMPOUND AND LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2021-11-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210359215-A1 COMPOUND AND LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, SIRT1 ACP1 4450/4885GABRG2 4297/4885GABRB3 4337/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback